Telmitri One 40/5/5 mg (Telmisartan, Amlodipine, Rosuvastatin)

Adult dose

This medication is taken once daily, one tablet, with water regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). The dose of the telmisartan/amlodipine combination should be individualized for each patient based on their blood pressure control status, as follows: - 40/5 mg: Administered to patients whose blood pressure is not adequately controlled with 5 mg of amlodipine or 40 mg of telmisartan. - 80/5 mg.

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, thus it must be discontinued immediately upon confirmation of pregnancy. Additionally, women of childbearing potential should use appropriate contraceptive measures, and breastfeeding women should avoid taking this medication. Patients with allergies to any of the components of this drug or specific liver or kidney diseases should not take it. Particularly, patients with severe liver dysfunction or kidney dysfunction should also avoid administration. Caution is required when administering to the elderly, patients with hypotension, or those with hyperkalemia, and regular liver function tests or muscle-related exams should be conducted. If symptoms such as muscle pain or weakness occur, consultation with a doctor should be sought immediately, and drug use may be discontinued in severe cases. This medication may interact with other drugs, and if the patient is taking other medications, they must inform their doctor or pharmacist. In case of overdose, symptoms such as hypotension, dizziness, and cardiac arrhythmias may occur, and appropriate medical treatment should be sought immediately. This medication is not recommended for children as its safety and efficacy have not been sufficiently established.

Serious side effects

Urticaria, severe swelling (edema), angioedema, anaphylactic reaction, Stevens-Johnson syndrome, DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms), jaundice, liver dysfunction, hepatitis, acute liver failure, severe skin adverse reactions, severe allergic reactions, severe edema, elevated serum transaminases (more than three times the upper limit of normal), thrombocytopenia, increased serum creatinine, acute renal failure, rhabdomyolysis.

Mild side effects

• Headache
• dizziness
• lightheadedness
• drowsiness
• palpitations
• fatigue
• weakness
• malaise
• pain
• nausea

This medication should be kept in a tightly closed container that protects it from light, and it is recommended to store it at room temperature between 1 and 30 degrees Celsius. Storing it this way will maintain its effectiveness and safety.

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/bottle